Old API Wind-down Ltd - Ordinary Shares ARLZQ

Remember

[bunser]

the good old days when TRX was a stand alone, promising stock on Venture exchange. Then Pozen came along. Sorry guys .Just venting. I am still long, I know it will take time. Just hoping for a positive NR shortly on an acquisition or drug approval.

[kuatolives]

I think market sentiment for ARLZ might turn around quicker than you think if/when yosprala gets approved as Valeant has pretty much shattered the growth through acquisition business model for specialty pharma. The ability to claim a signifiant % of your revenue comes from home grown developed drugs rather than jacking up the price of acquired ones may be the pharma business model the market once